Stefan Gingele

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany - expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN).

Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany - expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN).

Journal: Neurological research and practice

Published: May 27, 2026

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.

Journal: Neurological research and practice

Published: December 19, 2025

Divergent Immunological and Neurotrophic Responses to CD20 Depletion in Relapsing and Progressive Multiple Sclerosis.

Divergent Immunological and Neurotrophic Responses to CD20 Depletion in Relapsing and Progressive Multiple Sclerosis.

Journal: Neurology and therapy

Published: December 18, 2025

Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity.

Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 04, 2025

Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis.

Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis.

Journal: Frontiers in neurology

Published: October 06, 2025

Psoriasis under B-cell depleting therapies in multiple sclerosis: a retrospective multicenter analysis.

Psoriasis under B-cell depleting therapies in multiple sclerosis: a retrospective multicenter analysis.

Journal: Therapeutic advances in neurological disorders

Published: October 02, 2025

Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.

Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.

Journal: Neurology and therapy

Published: July 29, 2025

Prognostic implications of right ventricular to pulmonary artery uncoupling in cardiac amyloidosis.

Prognostic implications of right ventricular to pulmonary artery uncoupling in cardiac amyloidosis.

Journal: Frontiers in cardiovascular medicine

Published: June 25, 2025

Does Interrater Variation Influence the Classification According to the Diagnostic Criteria for Multiple Sclerosis?

Does Interrater Variation Influence the Classification According to the Diagnostic Criteria for Multiple Sclerosis?

Journal: European journal of neurology

Published: June 09, 2025

Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab.

Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab.

Journal: Neurological research and practice

Published: May 20, 2025

A new screening tool for early recognition of ATTRv polyneuropathy in clinical practice: AmyloScan®.

A new screening tool for early recognition of ATTRv polyneuropathy in clinical practice: AmyloScan®.

Journal: Journal of neurology

Published: May 19, 2025

Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study).

Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study).

Journal: Frontiers in immunology

Published: February 12, 2025

Showing 1-12 of 82

Last Updated: 09/26/2026